Wu F, Wu J, Ehley J, Filutowicz M
Department of Bacteriology, University of Wisconsin-Madison 53706, USA.
J Bacteriol. 1996 Aug;178(16):4965-74. doi: 10.1128/jb.178.16.4965-4974.1996.
Fis protein is shown here to bind to 10 sites in the gamma origin of plasmid R6K. The Fis-binding sites overlap all the previously identified binding sites in the gamma origin for the plasmid-encoded pi initiator protein and three host-encoded proteins, DnaA, integration host factor, and RNA polymerase. However, the requirement of Fis for R6K replication depends on the use of copy-up pi-protein variants and, oddly, the antibiotic resistance marker on the plasmid. In Fis-deficient cells, copy-up pi variants cannot drive replication of R6K gamma-origin plasmids carrying the bla gene encoding resistance to penicillin (Penr) but can drive replication of plasmids with the same origin but carrying the chloramphenicol acetyltransferase gene encoding chloramphenicol resistance (Cmr). In contrast, R6K replication driven by wild-type pi is unaffected by the antibiotic resistance marker in the absence of Fis protein. Individually, none of these elements (copy-up pi, Fis deficiency, or drug markers) prevents R6K replication. The replication defect is not caused by penicillin in the medium or runaway replication and is unaffected by the orientation of the bla gene relative to the origin. Replication remains inhibited when part of the bla coding segment is deleted but the bla promoter is left intact. However, replication is restored by insertion of transcriptional terminators on either side of the gamma origin, suggesting that excess transcription from the bla gene may inactivate replication driven by pi copy-up mutants in the absence of Fis. This study suggests that vector sequences such as drug markers may not be inconsequential in replication studies, as is generally assumed.
本文显示Fis蛋白可与质粒R6K的γ-ori中的10个位点结合。Fis结合位点与γ-ori中先前鉴定出的质粒编码的π起始蛋白以及三种宿主编码蛋白(DnaA、整合宿主因子和RNA聚合酶)的所有结合位点重叠。然而,Fis对R6K复制的需求取决于拷贝数增加型π蛋白变体的使用,奇怪的是,还取决于质粒上的抗生素抗性标记。在缺乏Fis的细胞中,拷贝数增加型π变体无法驱动携带编码对青霉素抗性(Penr)的bla基因的R6Kγ-ori质粒的复制,但可以驱动具有相同ori但携带编码氯霉素抗性(Cmr)的氯霉素乙酰转移酶基因的质粒的复制。相比之下,在没有Fis蛋白的情况下,由野生型π驱动的R6K复制不受抗生素抗性标记的影响。单独来看,这些元件(拷贝数增加型π、Fis缺陷或药物标记)都不会阻止R6K复制。复制缺陷不是由培养基中的青霉素或失控复制引起的,并且不受bla基因相对于ori的方向的影响。当bla编码片段的一部分被删除但bla启动子保持完整时,复制仍然受到抑制。然而,通过在γ-ori两侧插入转录终止子可恢复复制,这表明在没有Fis的情况下,来自bla基因的过量转录可能会使由π拷贝数增加突变体驱动的复制失活。这项研究表明,载体序列如药物标记在复制研究中可能并非如通常所认为的那样无关紧要。